This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Jan;207(1):106-107.

doi: 10.1097/JU.0000000000002182.03. Epub 2021 Oct 11.

Reply by Authors

Cheyenne Williams¹, Michael Ahdoot¹, Michael A Daneshvar¹, Christian Hague¹, Andrew R Wilbur¹, Patrick T Gomella¹, Joanna Shih², Nabila Khondakar¹, Nitin Yerram¹, Sherif Mehralivand³, Sandeep Gurram¹, Minhaj Siddiqui⁴, Paul Pinsky⁵, Howard Parnes⁵, Maria Merino⁶, Bradford Wood⁷, Baris Turkbey³, Peter A Pinto¹

Affiliations

Affiliations

¹ Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
³ Molecular Imaging Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
⁴ Director of Urologic Oncology and Robotic Surgery, VA Medical Center, University of Maryland, Baltimore, Maryland.
⁵ Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁶ Translational Surgical Pathology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁷ Center for Interventional Oncology, National Cancer Institute, & Interventional Radiology, Radiology and Imaging Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 34633213
DOI: 10.1097/JU.0000000000002182.03

Comment

Reply by Authors

Cheyenne Williams et al. J Urol. 2022 Jan.

. 2022 Jan;207(1):106-107.

doi: 10.1097/JU.0000000000002182.03. Epub 2021 Oct 11.

Authors

Cheyenne Williams¹, Michael Ahdoot¹, Michael A Daneshvar¹, Christian Hague¹, Andrew R Wilbur¹, Patrick T Gomella¹, Joanna Shih², Nabila Khondakar¹, Nitin Yerram¹, Sherif Mehralivand³, Sandeep Gurram¹, Minhaj Siddiqui⁴, Paul Pinsky⁵, Howard Parnes⁵, Maria Merino⁶, Bradford Wood⁷, Baris Turkbey³, Peter A Pinto¹

Affiliations

¹ Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
³ Molecular Imaging Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
⁴ Director of Urologic Oncology and Robotic Surgery, VA Medical Center, University of Maryland, Baltimore, Maryland.
⁵ Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁶ Translational Surgical Pathology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁷ Center for Interventional Oncology, National Cancer Institute, & Interventional Radiology, Radiology and Imaging Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 34633213
DOI: 10.1097/JU.0000000000002182.03

No abstract available

PubMed Disclaimer

Comment on

Editorial Comment.
Marks LS, Brisbane WG. Marks LS, et al. J Urol. 2022 Jan;207(1):105. doi: 10.1097/JU.0000000000002182.01. Epub 2021 Oct 11. J Urol. 2022. PMID: 34633211 No abstract available.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.